Disparities in cardiovascular disease mortality after breast cancer treatment: methodological considerations using real-world data Published December 2021 Citation Calip, GS, Brown-Wade, N, Guadamuz, JS, Wang, X, Miksad, RA, Whitaker, K. . Cancer. . https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.34045 Authors:Calip, GS, Brown-Wade, N, Guadamuz, JS, Wang, X, Miksad, RA, Whitaker, K Sources:Cancer Share Posted inPublicationsHealth equityBreast cancer More publicationsAACR Special Conference in Cancer Research: Artificial Intelligence and Machine LearningJuly 2025Fairness by design: End-to-end bias evaluation for LLM-generated dataEstevez M, Mbah O, Sheikh A, et al.Publication summaryPublicationsData scienceHealth equityBreast cancerArtificial intelligenceESMO OpenJanuary 2026Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world dataTolaney SM, Sammons S, Sandoval-Leon A, et al.Publication summaryPublicationsBreast cancerSABCSDecember 2025Real-world glucagon-like peptide-1 use and association with clinical characteristics, social determinants, and circulating tumor DNA positivity in patients with breast cancerRyals C, Blarre A, Adamson B, et al.Publication summaryPublicationsBreast cancer